LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapeutics Theonys's focus on reprogramming tRNA networks to develop targeted, re-dosable medicines offers opportunities to collaborate with pharmaceutical companies interested in precision gene therapies and rare disease treatments.

Funding & Growth With $11M in funding and early-stage revenue under $1M, Theonys presents a potential partnership for investors or industry players seeking to support groundbreaking biotech innovations in the gene therapy space.

Research Expertise Founded by pioneers from MIT and Harvard, Theonys's deep scientific expertise in tRNA signaling positions it as a valuable partner for biotech firms aiming to accelerate discovery in complex genetic disorders.

Tech Adoption The company's tech stack, including AWS and modern front-end tools, indicates a focus on leveraging advanced technology for innovative research, which could be of interest to tech companies seeking biotech collaborations.

Market Niche Operating in the frontier biotech sector with a specialized focus on genetically driven diseases, Theonys's niche positioning allows for targeted outreach to specialty pharma and venture capitalists investing in cutting-edge genetic medicines.

Theonys Tech Stack

Theonys uses 5 technology products and services including Amazon Web Services, Open Graph, Netlify, and more. Explore Theonys's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Open Graph
    Content Management System
  • Netlify
    Platform As A Service
  • HSTS
    Security
  • Tailwind CSS
    UI Frameworks

Media & News

Theonys's Email Address Formats

Theonys uses at least 1 format(s):
Theonys Email FormatsExamplePercentage
First.Last@theonys.comJohn.Doe@theonys.com
50%
First.Last@theonys.comJohn.Doe@theonys.com
50%

Frequently Asked Questions

Where is Theonys's headquarters located?

Minus sign iconPlus sign iconTheonys's main headquarters is located at Cambridge, Massachusetts 02139 United States. The company has employees across 1 continents, including North America.

What is Theonys's official website and social media links?

Minus sign iconPlus sign iconTheonys's official website is theonys.com and has social profiles on LinkedIn.

What is Theonys's SIC code NAICS code?

Minus sign iconPlus sign iconTheonys's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Theonys have currently?

Minus sign iconPlus sign iconAs of December 2025, Theonys has approximately 13 employees across 1 continents, including North America. Key team members include Vp & Head Of Pharmacology (interim): M. P.Executive Assistant To Chief Executive Officer And Office Manager: I. D.. Explore Theonys's employee directory with LeadIQ.

What industry does Theonys belong to?

Minus sign iconPlus sign iconTheonys operates in the Biotechnology Research industry.

What technology does Theonys use?

Minus sign iconPlus sign iconTheonys's tech stack includes Amazon Web ServicesOpen GraphNetlifyHSTSTailwind CSS.

What is Theonys's email format?

Minus sign iconPlus sign iconTheonys's email format typically follows the pattern of First.Last@theonys.com. Find more Theonys email formats with LeadIQ.

How much funding has Theonys raised to date?

Minus sign iconPlus sign icon As of December 2025, Theonys has raised $11M in funding. The last funding round occurred on Feb 23, 2021 for $11M.

When was Theonys founded?

Minus sign iconPlus sign iconTheonys was founded in 2020.

Theonys

Biotechnology ResearchMassachusetts, United States11-50 Employees

Theonys is a frontier biotech company leveraging deep insights into how genes are turned into proteins to expand the therapeutic universe for patients in need. We’re working to harness the power of transfer RNA (tRNA) signaling to unlock a new paradigm in the treatment, prevention and cure of complex, multigenic diseases. 

We’ve discovered how to reprogram tRNA networks and restore homeostasis in patients suffering from genetically driven disorders — opening the door to developing new targeted, redosable medicines that treat known causes of cancer, inflammatory disorders and severe rare diseases.

Theonys was founded by a team of tRNA pioneers and experienced drug hunters at MIT and Harvard in 2020, and is proudly backed by Leaps (Bayer), Xora Innovation (Temasek), Humboldt Fund, Emerson Collective and Alexandria Venture Investments.

Visionaries dream. Innovators create. We are both.

Section iconCompany Overview

Headquarters
Cambridge, Massachusetts 02139 United States
Website
theonys.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $11M

    Theonys has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Feb 23, 2021 in the amount of $11M.

  • $1M

    Theonys's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $11M

    Theonys has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Feb 23, 2021 in the amount of $11M.

  • $1M

    Theonys's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    M. P.
    Vp & Head Of Pharmacology (interim)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. D.
    Executive Assistant To Chief Executive Officer And Office Manager
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.